Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Jan-24 5:30 PM View:  | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 18,908 | $0.67 | $12,725.10 | (48%) 39.11K to 20.2K | |
| 17-Jan-24 5:30 PM View: | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 4,681 | $0.79 | $3,697.99 | (40%) 11.7K to 7.02K | |
| 12-Jan-24 5:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 5,220 | $0.85 | $4,458.40 | (40%) 13.09K to 7.87K | |
| 12-Jan-24 5:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 4,009 | $0.84 | $3,354.33 | (40%) 10.11K to 6.1K | |
| 17-Jan-23 9:17 PM View: | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 4,440 | $1.86 | $8,249.52 | (38%) 11.7K to 7.26K | |
| 12-Jan-23 9:03 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 4,973 | $1.71 | $8,483.94 | (38%) 13.09K to 8.12K | |
| 12-Jan-23 9:03 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 3,843 | $1.75 | $6,712.95 | (38%) 10.11K to 6.27K | |
| 04-Jan-23 9:02 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 3,584 | $1.69 | $6,071.30 | (38%) 9.37K to 5.78K | |
| 17-Jun-22 4:23 PM View: | Ardelyx, Inc. (ARDX) | 15-Jun-22 | Grant | 118,613 | -- | -- | 142% 83.55K to 202.16K | |
| 18-Jan-22 9:04 PM View: | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 4,368 | $3.19 | $13,941.80 | (37%) 11.7K to 7.34K | (9%) |
| 13-Jan-22 9:02 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-22 | Market Sale | 2,248 | $3.54 | $7,967.14 | (37%) 6.0K to 3.75K | 2% |
| 13-Jan-22 9:02 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-22 | Market Sale | 3,770 | $3.56 | $13,408.80 | (37%) 10.11K to 6.34K | 2% |
| 05-Jan-22 9:08 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-22 | Market Sale | 3,490 | $4.06 | $14,184.10 | (37%) 9.36K to 5.87K | 6% |
| 02-Jul-21 8:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 02-Jul-21 | Market Sale | 4,375 | $4.26 | $18,658.90 | (37%) 11.7K to 7.33K | (1%) |
| 21-Jun-21 4:11 PM View: | Ardelyx, Inc. (ARDX) | 16-Jun-21 | Grant | 8,891 | -- | -- | 12% 74.66K to 83.55K | |
| 12-Jan-21 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-21 | Market Sale | 2,234 | $6.15 | $13,744.00 | (37%) 6.0K to 3.77K | (1%) |
| 05-Jan-21 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-21 | Market Sale | 3,499 | $5.33 | $18,642.30 | (37%) 9.36K to 5.86K | (13%) |
| 15-Dec-20 4:22 PM View: | Ardelyx, Inc. (ARDX) | 14-Dec-20 | Grant | 15,000 | $7.08 | $106,256.00 | 25% 59.66K to 74.66K | (< 1%) |
| 15-Dec-20 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Dec-20 | Private Purchase | 207,000 | $0.69 | $143,824.00 | 266% 77.81K to 284.81K | |
| 11-Jun-20 6:34 PM View: | Ardelyx, Inc. (ARDX) | 09-Jun-20 | Grant | 7,523 | -- | -- | 14% 52.13K to 59.66K | |
| 15-Jan-20 8:03 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Jan-20 | Market Sale | 2,397 | $5.13 | $12,307.90 | (40%) 6.0K to 3.6K | (4%) |
| 07-Jan-20 8:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 06-Jan-20 | Market Sale | 3,731 | $1.20 | $4,477.20 | (40%) 9.36K to 5.63K | (343%) |
| 17-Jun-19 4:31 PM View: | Ardelyx, Inc. (ARDX) | 13-Jun-19 | Grant | 18,248 | -- | -- | 54% 33.89K to 52.13K | |
| 16-Jan-19 9:31 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Jan-19 | Market Sale | 2,271 | $5.37 | $12,193.90 | (38%) 6.0K to 3.73K | (< 1%) |
| 15-Jun-18 6:57 PM View: | Ardelyx, Inc. (ARDX) | 13-Jun-18 | Grant | 12,406 | -- | -- | 58% 21.48K to 33.89K | |
| 09-Jun-17 7:05 PM View: | Ardelyx, Inc. (ARDX) | 07-Jun-17 | Grant | 11,627 | -- | -- | 118% 9.85K to 21.48K | |
| 06-Jun-16 7:36 PM View: | Ardelyx, Inc. (ARDX) | 02-Jun-16 | Grant | 4,854 | -- | -- | 97% 5.0K to 9.85K | |
| 21-Dec-15 9:35 PM View: | Ardelyx, Inc. (ARDX) | 17-Dec-15 | Market Purchase | 5,000 | $20.00 | $100,000.00 | 100% 0 to 5.0K | (68%) |
| 03-Apr-15 11:36 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition | 28,289 | $173.00 | $4,894,000.00 | (91%) 31.26K to 2.97K | |
| 03-Apr-15 11:36 AM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 01-Apr-15 | Disposition (change in control) | 2,969 | $173.00 | $513,637.00 | (100%) 2.97K to 0 | |
| 03-Feb-15 4:15 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 31-Jan-15 | Grant | 2,851 | -- | -- | 10% 28.41K to 31.26K | |
| 26-Jul-13 4:15 PM View: | Salix Pharmaceuticals Ltd. (SLXPE.OB) | 24-Jul-13 | Grant | 14,428 | -- | -- | 100% 0 to 14.43K | |
| 05-Jun-07 12:47 PM View: | Medimmune Inc /de (MEDI) | 01-Jun-07 | Disposition (change in control) | 2,536 | $58.00 | $147,088.00 | (100%) 2.54K to 0 | < 1% |